Lv1
8 积分 2024-10-18 加入
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
21小时前
已完结
Challenges in carrier-mediated intracellular delivery: moving beyond endosomal barriers
1个月前
已完结
Endosomal escape: a bottleneck for LNP-mediated therapeutics
1个月前
已完结
Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials
1个月前
已完结
Validation of an HPLC-CAD Method for Determination of Lipid Content in LNP-Encapsulated COVID-19 mRNA Vaccines
1个月前
已完结
A preparation method for mRNA-LNPs with improved properties
1个月前
已完结
High-Precision Synthesis of RNA-Loaded Lipid Nanoparticles for Biomedical Applications
1个月前
已完结
Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs
3个月前
已完结
Buffer Specificity of Ionizable Lipid Nanoparticle Transfection Efficiency and Bulk Phase Transition
3个月前
已完结
Modulating Lipid Nanoparticles with Histidinamide-Conjugated Cholesterol for Improved Intracellular Delivery of mRNA
3个月前
已完结
皖公网安备34019202002308
